In the last week, the Life Sciences industry is up 1.7%, with Danaher up 4.9%. In the last 12 months, the industry was up 9.0%. Looking forward, earnings are forecast to grow by 17% annually.
Has the U.S. Life Sciences Industry valuation changed over the past few years?
Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
---|---|---|---|---|---|---|
Mon, 20 May 2024 | US$741.1b | US$141.5b | US$12.4b | 38.2x | 59.6x | 5.2x |
Wed, 17 Apr 2024 | US$703.0b | US$142.0b | US$12.8b | 42.2x | 55x | 4.9x |
Fri, 15 Mar 2024 | US$753.0b | US$142.1b | US$12.8b | 44.6x | 58.7x | 5.3x |
Sun, 11 Feb 2024 | US$708.4b | US$141.9b | US$12.7b | 39.7x | 55.7x | 5x |
Tue, 09 Jan 2024 | US$684.7b | US$153.9b | US$14.2b | 37x | 48.3x | 4.5x |
Thu, 07 Dec 2023 | US$648.0b | US$153.7b | US$14.0b | 35.3x | 46.3x | 4.2x |
Sat, 04 Nov 2023 | US$597.3b | US$153.9b | US$11.0b | 31.5x | 54.2x | 3.9x |
Mon, 02 Oct 2023 | US$672.6b | US$154.6b | US$11.2b | 33.3x | 60x | 4.4x |
Wed, 30 Aug 2023 | US$733.4b | US$154.6b | US$11.2b | 33.4x | 65.4x | 4.7x |
Fri, 28 Jul 2023 | US$751.7b | US$154.7b | US$11.8b | 30.4x | 63.7x | 4.9x |
Sun, 25 Jun 2023 | US$690.9b | US$152.4b | US$12.5b | 29.3x | 55.3x | 4.5x |
Tue, 23 May 2023 | US$689.0b | US$152.1b | US$12.5b | 29x | 55.2x | 4.5x |
Thu, 20 Apr 2023 | US$736.5b | US$154.6b | US$10.8b | 30.2x | 68.2x | 4.8x |
Sat, 18 Mar 2023 | US$701.0b | US$154.5b | US$10.8b | 27.3x | 64.8x | 4.5x |
Mon, 13 Feb 2023 | US$745.6b | US$155.6b | US$8.7b | 30.6x | 85.6x | 4.8x |
Wed, 11 Jan 2023 | US$743.5b | US$155.2b | US$8.8b | 29.9x | 84.7x | 4.8x |
Fri, 09 Dec 2022 | US$772.3b | US$155.1b | US$8.8b | 29x | 88x | 5x |
Sun, 06 Nov 2022 | US$706.9b | US$154.9b | US$9.1b | 25.8x | 78x | 4.6x |
Tue, 04 Oct 2022 | US$722.6b | US$152.5b | US$17.0b | 23.8x | 42.5x | 4.7x |
Thu, 01 Sep 2022 | US$759.4b | US$152.3b | US$17.3b | 29x | 43.9x | 5x |
Sat, 30 Jul 2022 | US$834.2b | US$151.6b | US$18.2b | 33.5x | 45.7x | 5.5x |
Mon, 27 Jun 2022 | US$731.0b | US$148.1b | US$20.1b | 30.5x | 36.4x | 4.9x |
Wed, 25 May 2022 | US$730.6b | US$148.0b | US$20.0b | 30.5x | 36.4x | 4.9x |
Fri, 22 Apr 2022 | US$838.6b | US$146.5b | US$25.3b | 34.8x | 33.1x | 5.7x |
Sun, 20 Mar 2022 | US$874.0b | US$145.3b | US$25.1b | 37x | 34.8x | 6x |
Tue, 15 Feb 2022 | US$856.1b | US$143.8b | US$24.9b | 38.8x | 34.4x | 6x |
Thu, 13 Jan 2022 | US$921.4b | US$138.0b | US$27.3b | 42.2x | 33.7x | 6.7x |
Sat, 11 Dec 2021 | US$959.4b | US$138.0b | US$27.3b | 43.1x | 35.1x | 7x |
Mon, 08 Nov 2021 | US$950.5b | US$137.6b | US$27.2b | 45.9x | 35x | 6.9x |
Wed, 06 Oct 2021 | US$701.2b | US$105.9b | US$18.6b | 46.2x | 37.6x | 6.6x |
Fri, 03 Sep 2021 | US$754.2b | US$105.8b | US$18.7b | 52x | 40.4x | 7.1x |
Sun, 01 Aug 2021 | US$707.4b | US$105.8b | US$18.7b | 43.3x | 37.9x | 6.7x |
34.4x
Which industries have driven the changes within the U.S. Healthcare industry?
US Market | 1.79% | |
Healthcare | 1.86% | |
Life Sciences | 2.24% | |
Clinical Research and Equipment | 2.24% |
Which companies have driven the market over the last 7 days?
Company | Last Price | 7D | 1Y | Valuation | |
---|---|---|---|---|---|
DHR Danaher | US$265.80 | 5.6% +US$10.5b | 14.9% | PE48.4x | |
A Agilent Technologies | US$154.23 | 4.4% +US$1.9b | 19.5% | PE36.6x | |
TMO Thermo Fisher Scientific | US$595.30 | 0.8% +US$1.8b | 12.5% | PE37.7x | |
MTD Mettler-Toledo International | US$1.52k | 4.2% +US$1.3b | 8.9% | PE41.8x | |
RVTY Revvity | US$110.23 | 4.4% +US$577.5m | -8.3% | PE74.2x |